| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5502849 | Journal of the Neurological Sciences | 2017 | 6 Pages |
Abstract
We demonstrated that a high proportion of patients with very high VGKC-complex antibody levels and relevant clinical syndromes have LGI1 and/or CASPR2 antibodies detected by the commercial assay. Our findings lend support to the use of the assay for rapid and reliable detection of LGI1 and CASPR2 antibodies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
T. Yeo, Z. Chen, J.Y.H. Chai, K. Tan,